Mosaic ImmunoEngineering (CPMV) Other Operating Expenses (2010 - 2023)
Mosaic ImmunoEngineering (CPMV) posted quarterly Other Operating Expenses of -$6000.0 for Q3 2023, up 98.8% year-over-year from -$3018.2 in Q3 2022, and up 98.64% quarter-over-quarter from -$441891.0 in Q1 2023.
Mosaic ImmunoEngineering (CPMV) Other Operating Expenses (2010 - 2023) Analysis & Trends
Mosaic ImmunoEngineering's Other Operating Expenses history runs 5 years deep, the most recent figure standing at -$6000.0 for Q3 2023.
- In Q3 2023, Other Operating Expenses rose 98.8% year-over-year to -$6000.0; the TTM figure through Jun 2024 stood at -$6000.0 (up 99.36% YoY), while the FY2023 annual figure was -$6200.0, changed N/A from the prior year.
- Other Operating Expenses for Q3 2023 stood at -$6000.0, up from -$441891.0 in the prior quarter.
- The five-year high for Other Operating Expenses was $2.7 million in Q4 2021, with the low at -$949462.0 in Q3 2021.
- The 3-year median for Other Operating Expenses is -$470306.5 (2022), against an average of -$7140.3.
- The sharpest annual moves came in 2022 and 2023: Other Operating Expenses surged 47.47% in 2022, then soared 98.8% in 2023.
- Mosaic ImmunoEngineering's Other Operating Expenses stood at $2.7 million in 2021, then sank by 118.77% to -$498722.0 in 2022, then jumped by 98.8% to -$6000.0 in 2023.
- Business Quant data shows CPMV's Other Operating Expenses at -$6000.0 in Q3 2023, -$441891.0 in Q1 2023, and -$498722.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Mosaic ImmunoEngineering | 3.68 Mn | 3.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -6,000.00 |
| Mar 31, 2023 | -441,891.00 |
| Sep 30, 2022 | -498,722.00 |
| Dec 31, 2021 | 2.66 Mn |
| Sep 30, 2021 | -949,462.00 |
| Mar 31, 2021 | -804,448.00 |
| Nov 30, 2011 | -150,757.00 |
| Aug 31, 2011 | -170,195.00 |
| Aug 31, 2010 | 60,000.00 |